{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:07:44Z","timestamp":1792480064248,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.acra.2026.04.042","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:06:27Z","timestamp":1779249987000},"page":"3850-3861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mid-Treatment Delta MRI Radiomics Enhances Sensitivity and Risk Stratification for Pathological Complete Response in Breast Cancer: A Multicenter Study"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4531-7541","authenticated-orcid":false,"given":"Hong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruofan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suidan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.acra.2026.04.042_bib1","first-page":"477","article-title":"Breast cancer statistics, 2024","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.acra.2026.04.042_bib2","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/jamaoncol.2024.3456","article-title":"Neoadjuvant and adjuvant immune checkpoint inhibitor therapy in early breast cancer: a systematic review and individual patient data meta-analysis","volume":"10","author":"Villacampa","year":"2024","journal-title":"JAMA Oncol"},{"issue":"22","key":"10.1016\/j.acra.2026.04.042_bib3","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1200\/JCO.23.02614","article-title":"Neoadjuvant chemotherapy and immunotherapy for estrogen receptor-positive human epidermal growth factor 2-negative breast cancer","volume":"42","author":"R\u00edos-Hoyo","year":"2024","journal-title":"J Clin Oncol"},{"issue":"9938","key":"10.1016\/j.acra.2026.04.042_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.acra.2026.04.042_bib5","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1158\/1078-0432.CCR-19-3492","article-title":"Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis","volume":"26","author":"Spring","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"18","key":"10.1016\/j.acra.2026.04.042_bib6","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1200\/JCO.24.00886","article-title":"Optimal adjuvant chemotherapy and targeted therapy for early breast cancer\u2014cyclin-dependent kinase 4 and 6 inhibitors: ASCO guideline rapid recommendation update","volume":"42","author":"Freedman","year":"2024","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.acra.2026.04.042_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13244-013-0219-y","article-title":"The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review","volume":"4","author":"Lobbes","year":"2013","journal-title":"Insights Imaging"},{"key":"10.1016\/j.acra.2026.04.042_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2019.108736","article-title":"Exploring breast cancer response prediction to neoadjuvant systemic therapy using MRI-based radiomics: a systematic review","volume":"121","author":"Granzier","year":"2019","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.acra.2026.04.042_bib9","article-title":"Neoadjuvant chemotherapy for breast cancer: an evaluation of its efficacy and research progress","volume":"13","author":"Chen","year":"2023","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.acra.2026.04.042_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jmri.28273","article-title":"Four-dimensional machine learning radiomics for the pretreatment assessment of breast cancer pathologic complete response to neoadjuvant chemotherapy in dynamic contrast-enhanced MRI","volume":"57","author":"Caballo","year":"2023","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"10.1016\/j.acra.2026.04.042_bib11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/cncr.34540","article-title":"Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: a multicenter study","volume":"129","author":"Gu","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.acra.2026.04.042_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1264259","article-title":"Longitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer","volume":"13","author":"Panthi","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.acra.2026.04.042_bib13","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11547-024-01853-4","article-title":"Delta radiomics: an updated systematic review","volume":"129","author":"Nardone","year":"2024","journal-title":"Radiol Med"},{"key":"10.1016\/j.acra.2026.04.042_bib14","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1158\/1078-0432.CCR-18-3190","article-title":"Radiomics of multiparametric MRI for pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: a multicenter study","volume":"25","author":"Liu","year":"2019","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.acra.2026.04.042_bib15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10549-018-4990-9","article-title":"Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set","volume":"173","author":"Cain","year":"2019","journal-title":"Breast Cancer Res\u00a0Treat"},{"issue":"1","key":"10.1016\/j.acra.2026.04.042_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48465-x","article-title":"Prediction of treatment response to neoadjuvant chemotherapy for breast cancer via early changes in tumor heterogeneity captured by DCE-MRI registration","volume":"9","author":"Jahani","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.acra.2026.04.042_bib17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13058-018-0950-x","article-title":"MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer","volume":"20","author":"Goorts","year":"2018","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.acra.2026.04.042_bib18","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41598-017-00665-z","article-title":"Delta-radiomics features for the prediction of patient outcomes in non-small cell lung cancer","volume":"7","author":"Fave","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.acra.2026.04.042_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41698-019-0096-z","article-title":"A machine learning based delta-radiomics process for early prediction of treatment response of pancreatic cancer","volume":"3","author":"Nasief","year":"2019","journal-title":"NPJ Precis Oncol"},{"issue":"2","key":"10.1016\/j.acra.2026.04.042_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"20","key":"10.1016\/j.acra.2026.04.042_bib21","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline focused update","volume":"36","author":"Wolf","year":"2018","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.acra.2026.04.042_bib22","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J Clin Oncol"},{"issue":"58","key":"10.1016\/j.acra.2026.04.042_bib23","article-title":"Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study","volume":"24","author":"Huang","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10.1016\/j.acra.2026.04.042_bib24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1148\/radiol.2020191145","article-title":"The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping","volume":"295","author":"Zwanenburg","year":"2020","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.acra.2026.04.042_bib25","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1007\/s00330-025-11443-1","article-title":"Reproducibility of methodological radiomics score (METRICS): an intra- and inter-rater reliability study endorsed by EuSoMII","volume":"35","author":"Akinci D\u2032Antonoli","year":"2025","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.acra.2026.04.042_bib26","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1177\/0962280214558972","article-title":"Events per variable (EPV) and the relative performance of different strategies for estimating the out-of-sample validity of logistic regression models","volume":"26","author":"Austin","year":"2017","journal-title":"Stat Methods Med Res"},{"issue":"11","key":"10.1016\/j.acra.2026.04.042_bib27","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1093\/bioinformatics\/btw029","article-title":"FastLSU: a more practical approach for the Benjamini-Hochberg FDR controlling procedure for huge-scale testing problems","volume":"32","author":"Madar","year":"2016","journal-title":"Bioinformatics"},{"issue":"14","key":"10.1016\/j.acra.2026.04.042_bib28","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.3390\/s22145205","article-title":"A pipeline for the implementation and visualization of explainable machine learning for medical imaging using radiomics features","volume":"22","author":"Severn","year":"2022","journal-title":"Sensors"},{"issue":"1","key":"10.1016\/j.acra.2026.04.042_bib29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.18383\/j.tom.2018.00046","article-title":"Early prediction of breast cancer therapy response using multiresolution fractal analysis of DCE-MRI parametric maps","volume":"5","author":"Machireddy","year":"2019","journal-title":"Tomography"},{"issue":"5","key":"10.1016\/j.acra.2026.04.042_bib30","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/jmri.25279","article-title":"Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy","volume":"44","author":"Wu","year":"2016","journal-title":"J Magn Reson Imaging"},{"issue":"7","key":"10.1016\/j.acra.2026.04.042_bib31","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab emtansine for residual invasive HER2-positive breast cancer","volume":"380","author":"Von Minckwitz","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.acra.2026.04.042_bib32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jamaoncol.2015.6113","article-title":"Association of pathologic complete response to neoadjuvant therapy in HER2-positive breast cancer with long-term outcomes: a meta-analysis","volume":"2","author":"Broglio","year":"2016","journal-title":"JAMA Oncol"},{"issue":"7","key":"10.1016\/j.acra.2026.04.042_bib33","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1097\/JS9.0000000000002528","article-title":"Efficacy and safety of neoadjuvant ICI combined with chemotherapy in breast cancer from the perspective of a privileged population: a systematic review and meta-analysis","volume":"111","author":"Liu","year":"2025","journal-title":"Int J Surg"},{"issue":"5","key":"10.1016\/j.acra.2026.04.042_bib34","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.6004\/jnccn.2024.0035","article-title":"NCCN clinical practice guidelines in oncology (NCCN Guidelines) for breast cancer, Version 3","volume":"22","author":"Gradishar","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"10.1016\/j.acra.2026.04.042_bib35","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.acra.2023.04.009","article-title":"Radiomics based on DCE-MRI for predicting response to neoadjuvant therapy in breast cancer","volume":"30","author":"Zeng","year":"2023","journal-title":"Acad Radiol"},{"key":"10.1016\/j.acra.2026.04.042_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1249339","article-title":"Radiomic model based on magnetic resonance imaging for predicting pathological complete response after neoadjuvant chemotherapy in breast cancer patients","volume":"13","author":"Yu","year":"2024","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.acra.2026.04.042_bib37","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1158\/1078-0432.CCR-18-3190","article-title":"Radiomics of multiparametric MRI for pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: a multicenter study","volume":"25","author":"Liu","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.acra.2026.04.042_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.70347","article-title":"Integrating multiparametric MRI radiomics and clinical models to assess sensitivity to neoadjuvant chemotherapy in breast cancer: a multicenter study","volume":"26","author":"Zeng","year":"2025","journal-title":"J Appl Clin Med Phys"},{"issue":"1","key":"10.1016\/j.acra.2026.04.042_bib39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12911-025-02944-6","article-title":"The role of explainable artificial intelligence in disease prediction: a systematic literature review and future research directions","volume":"25","author":"Alkhanbouli","year":"2025","journal-title":"BMC Med Inform Decis Mak"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226003430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226003430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:55:31Z","timestamp":1787226931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633226003430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1076633226003430"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2026.04.042","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mid-Treatment Delta MRI Radiomics Enhances Sensitivity and Risk Stratification for Pathological Complete Response in Breast Cancer: A Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2026.04.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Association of Academic Radiology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}